Alphatec Holdings (ATEC) Price to Earnings Ratio

Corporate emblem and logo of Alphatec Holdings (ATEC)

Alphatec Holdings, Inc. (ATEC) develops comprehensive solutions for neurosurgeons, expanding its presence in vertebrology. An analysis of the company's P/E ratio allows for an assessment of market expectations, where -12.70 determines the current status of the parameter. High margins are achieved through unique treatment methodologies, while the aggressive implementation of robotics and neuromonitoring systems ensures the capture of market share from the industry's largest behemoths.

Alphatec Corp (ATEC) Price to Earnings Ratio: for the period 07/04/2022 - 11/16/2026

Comprehensive metric breakdowns and analytics for Alphatec (ATEC)

- price and consensus price forecast:
General company analysis:Alphatec Holdings - ATEC
Original product of atecspine.com

For Alphatec Holdings, Inc. (ATEC), which integrates high-tech systems into vertebrology, the efficiency of scaling B2B sales directly impacts capitalization. The P/E ratio compares the market value of shares with net earnings per share, determining the cost of each dollar of income and the extent of the asset's overvaluation. By analyzing the P/E trajectory of Alphatec Holdings, Inc. (ATEC), an investor identifies fair price corridors, balancing the risk of stagnation against growth overvaluation.

Analysis of competing companies

Price to Earnings Ratio BSX|Price to Earnings Ratio EW (Edwards Lifesciences Corporation)|Business Payback Period ResMed Inc.|P/E Multiple PODD (insulet.com)|ZBH (Zimmer Biomet Holdings, Inc.) - Market Cap to Net Income|CooperSurgical - P/E Multiple|Market Cap to Net Income ALGN|GMED: P/E Multiple|Market Cap to Earnings TransMedics Group (TMDX)|AORT (Artivion) - P/E Multiple|Price to Earnings Multiple ENOV (Enovis)|Price to Earnings Ratio IART (Integra LifeSciences Holdings Corporation)|ESTA (Establishment Labs Corp) - Company Value to Net Income|Price to Earnings Ratio iLet Bionic Pancreas BBNX|IRMD - Price to Earnings Ratio|Embecta Corp - P/E Multiple|Market Cap to Earnings Tandem Diabetes Care|AXGN: P/E Multiple|Price to Earnings Multiple SIBN|OFIX (Orthofix Corp) - P/E Multiple|Price to Earnings Ratio Bioventus Corp (BVS)|P/E Multiple KIDS|Price to Earnings Ratio Treace Medical Concepts TMCI|P/E Multiple SRTA (blade.com)|P/E Multiple Carlsmed, Inc. CARL|RXST - Price to Earnings Ratio|CLPT: Price to Earnings Ratio|STXS (Stereotaxis, Inc.) - Price to Earnings Ratio|Neuronetics, Inc. - Company Value to Net Income|SGHT (Sight Sciences Inc) - P/E Multiple|Market Cap to Earnings Orchestra BioMed Inc. OBIO|Price to Earnings Ratio Anika Therapeutics, Inc. (ANIK)|InspireMD, Inc. (NSPR) - Market Cap to Net Income Ratio|Jin Medical International Ltd. - Price to Earnings Ratio|P/E Multiple Vivani VANI|Xtant Medical Holdings, Inc. - P/E Multiple|Business Payback Period NeuroOne NMTC|Modular Medical, Inc. (MODD) - Price to Earnings Ratio|Price to Earnings Ratio Myomo, Inc|Price to Earnings Ratio envoymedical.com|Price to Earnings Ratio Vivos Therapeutics (VVOS)|P/E Multiple NVNO|SINT - Market Cap to Earnings|Price to Earnings Ratio Tenon Medical, Inc. TNON|LFWD: Price to Earnings Multiple|AMIX: Price to Earnings Ratio|Business Payback Period invobioscience.com IVF|BBLG: P/E Multiple|Axonics Modulation Technologies (AXNX) - P/E Multiple|BIOL (Biolase Inc.) - P/E Multiple|Market Cap to Earnings dynatronics.com DYNT|P/E Multiple FNA|Price to Earnings Ratio INVO (INVO Bioscience Inc.)